| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.46B | 3.40B | 3.29B | 3.08B | 2.89B | 2.58B |
| Gross Profit | 1.64B | 1.62B | 1.60B | 1.44B | 1.39B | 1.28B |
| EBITDA | 378.79M | 353.32M | 400.03M | 245.00M | 284.44M | 229.03M |
| Net Income | 35.14M | 14.95M | 173.68M | -185.98M | -54.33M | -85.23M |
Balance Sheet | ||||||
| Total Assets | 1.97B | 1.97B | 1.89B | 1.85B | 2.17B | 2.18B |
| Cash, Cash Equivalents and Short-Term Investments | 200.50M | 233.98M | 208.28M | 168.85M | 327.00M | 335.27M |
| Total Debt | 1.71B | 1.71B | 1.72B | 1.76B | 1.79B | 1.89B |
| Total Liabilities | 2.52B | 2.53B | 2.41B | 2.47B | 2.53B | 2.56B |
| Stockholders Equity | -571.26M | -583.49M | -550.15M | -623.14M | -494.92M | -449.37M |
Cash Flow | ||||||
| Free Cash Flow | 170.06M | 144.95M | 295.79M | 18.73M | 100.20M | 165.76M |
| Operating Cash Flow | 318.75M | 298.07M | 350.72M | 130.29M | 219.54M | 265.22M |
| Investing Cash Flow | -158.07M | -140.76M | -54.61M | -103.72M | -4.00M | -354.32M |
| Financing Cash Flow | -115.16M | -135.92M | -222.55M | -177.11M | -106.57M | 224.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $1.12B | 6.87 | 15.37% | ― | 0.32% | 69.78% | |
69 Neutral | $1.34B | 14.17 | 6.26% | ― | 5.70% | 97.88% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | $913.87M | 223.61 | 1.21% | 1.29% | 11.18% | ― | |
55 Neutral | $1.72B | 52.68 | ― | ― | 3.65% | -76.96% | |
46 Neutral | $887.47M | -19.12 | ― | ― | 31.28% | -22.05% |
On 17 December 2025, Cimpress plc, a Dublin‑registered mass‑customization and printing company, held its 2025 Annual General Meeting of Shareholders, with 24.7 million ordinary shares eligible to vote as of the 16 October 2025 record date. Shareholders reappointed Robert S. Keane and Scott J. Vassalluzzo to the board for three‑year terms ending at the 2028 AGM, approved on a non‑binding basis the compensation of named executive officers, renewed the board’s authority until 17 June 2027 to issue up to 20% of the company’s share capital and to disapply statutory pre‑emption rights for cash issuances up to the same limit, and reappointed PricewaterhouseCoopers Ireland as statutory auditor through the 2026 AGM with its remuneration to be set by the board or audit committee, thereby reinforcing management’s strategic flexibility in capital raising and confirming continuity in governance and audit oversight.
The most recent analyst rating on (CMPR) stock is a Buy with a $83.00 price target. To see the full list of analyst forecasts on Cimpress stock, see the CMPR Stock Forecast page.